PCN Insights, News, Videos, and More

Sleep Disorders Section Editor Karl Doghramji, MD, reviews the neurotransmitter systems governing sleep and wakefulness, the variety of prescription medications available for sleep difficulties, and agents that have recently been approved or...

Bipolar Disorders Section Editor Joseph F. Goldberg, MD, explains the utility and limitations of pharmacogenetics in the treatment of bipolar disorders.

Bipolar Disorders Section Editor Joseph F. Goldberg, MD, explains the concept of polarity-proneness and why clinicians should assess it when treating patients with bipolar disorder.

In this video, lead author Todd Lencz, PhD, discusses his study that found a gene mutation that could result in schizophrenia, possibly leading to novel treatment strategies.

Nancy Byatt, DO, MS, MBA, FACLP discusses the importance of treating perinatal individuals’ mental health and substance abuse disorders for the welfare of both themselves and their infant, and how recent research can impact policy in the...

John Torous, MD, MBI, gives an overview of a session at the upcoming American Psychiatric Association Annual Meeting that will examine how digital technology could be used to facilitate long-term recovery in patients with first episode...

Psych Congress Steering Committee member Rakesh Jain, MD, MPH, answers the question "What are the most common side effects of VMAT2 inhibitors and how can clinicians help patients manage them?"

Jessica Whelan, DNP, APRN, FPMHNP-BC reviews the many factors that come in to play when she is developing a treatment plan for her patients with bipolar disorder.

Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses recent guidelines on identifying and treating tardive dyskinesia.